Development of an integrated conceptual model of multiple sclerosis spasticity

被引:2
作者
Cameron, Michelle H. [1 ]
Bethoux, Francois [2 ]
Field-Fote, Edelle [3 ,4 ]
Lenderking, William R. [5 ]
Zaiser, Erica [6 ]
Cutts, Katelyn N. [5 ]
Wagner, Joanne M. [7 ,8 ]
Berwaerts, Joris [7 ,8 ]
Steinerman, Joshua R. [9 ,10 ]
机构
[1] OR Hlth & Sci Univ, Dept Neurol, Portland, OR USA
[2] Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH USA
[3] Shepherd Ctr, Crawford Res Inst, Atlanta, GA USA
[4] Emory Univ, Dept Rehabil Med, Sch Med, Atlanta, GA USA
[5] Evidera, Waltham, MA USA
[6] Evidera, London, England
[7] Greenwich Biosci Inc, Mt Prospect, IL USA
[8] Jazz Pharmaceut, Carlsbad, CA USA
[9] Jazz Pharmaceut Inc, Philadelphia, PA USA
[10] 2005 Market St,Suite 2100, Philadelphia, PA 19103 USA
关键词
Multiple sclerosis; muscle spasticity; conceptual model; qualitative research; interviews; SPINAL-CORD-INJURY; MOBILITY IMPROVEMENT; BOTULINUM TOXIN; SYMPTOMS; BURDEN; SATIVEX; DISEASE; STROKE; IMPACT; PAIN;
D O I
10.1080/09638288.2023.2237403
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
PurposeSpasticity is common in multiple sclerosis (MS), often leading to functional limitations and disability. We developed a conceptual model of spasticity in MS integrating expert opinion, recent literature, and experiences of clinicians and people with MS spasticity.MethodsA conceptual model was developed based on a targeted literature review of articles published between 2014 and 2019, followed by input from clinicians, then input from participants with MS spasticity. Multidisciplinary experts on spasticity provided guidance at each step.ResultsKey concepts of the integrated spasticity conceptual model included: moderators; triggers; modifiers; treatment; objective manifestations; subjective experience; physical, functional, social, and emotional/psychological impacts; and long-term consequences. Participants with MS spasticity most frequently endorsed spasms, tightness, and pain as descriptors of spasticity. Some participants with MS spasticity had difficulty distinguishing spasticity from other MS symptoms (e.g. muscle weakness). Some triggers, emotional/psychological impacts, and long-term consequences of spasticity reported by participants with MS spasticity were not previously identified in the published literature.ConclusionsThis conceptual model of spasticity, integrating published literature with the experience of clinicians, people with MS spasticity, and experts, demonstrates the complex, multidimensional nature of MS spasticity. This model may be used to improve clinician-patient dialogue, research, and patient care.
引用
收藏
页码:2955 / 2965
页数:11
相关论文
共 50 条
  • [31] Spasticity and everyday life in multiple sclerosis
    Donze, C.
    De Seze, J.
    REVUE NEUROLOGIQUE, 2012, 168 : S51 - S56
  • [32] A breakthrough for the treatment of spasticity in multiple sclerosis
    Lebrun, C.
    Vermersch, P.
    REVUE NEUROLOGIQUE, 2015, 171 (04) : 327 - 328
  • [33] Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis
    Wade, Derick T.
    Collin, Christine
    Stott, Colin
    Duncombe, Paul
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (06) : 707 - 714
  • [34] Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis.
    Schapiro R.T.
    Current Neurology and Neuroscience Reports, 2001, 1 (3) : 299 - 302
  • [35] Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis
    Letizia Leocani
    Arturo Nuara
    Elise Houdayer
    Irene Schiavetti
    Ubaldo Del Carro
    Stefano Amadio
    Laura Straffi
    Paolo Rossi
    Vittorio Martinelli
    Carlos Vila
    Maria Pia Sormani
    Giancarlo Comi
    Journal of Neurology, 2015, 262 : 2520 - 2527
  • [36] Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis
    Novarella, Federica
    Carotenuto, Antonio
    Cipullo, Paolo
    Iodice, Rosa
    Cassano, Emanuele
    Spiezia, Antonio Luca
    Capasso, Nicola
    Petracca, Maria
    Falco, Fabrizia
    Iacovazzo, Carmine
    Servillo, Giuseppe
    Lanzillo, Roberta
    Morra, Vincenzo Brescia
    Moccia, Marcello
    TOXINS, 2022, 14 (11)
  • [37] Assessing and treating pain associated with stroke, multiple sclerosis, cerebral palsy, spinal cord injury and spasticity Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation
    Paolucci, Stefano
    Martinuzzi, Andrea
    Scivoletto, Giorgio
    Smania, Nicola
    Solaro, Claudio
    Aprile, Irene
    Armando, Michela
    Bergamaschi, Roberto
    Berra, Eliana
    Berto, Giulia
    Carraro, Elena
    Cella, Monica
    Gandolfi, Marialuisa
    Masciullo, Marcella
    Molinari, Marco
    Pagliano, Emanuela
    Pecchioli, Cristiano
    Roncari, Laura
    Torre, Monica
    Trabucco, Erika
    Values, Gabriella
    Zerbinati, Paolo
    Tamburin, Stefano
    EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, 2016, 52 (06) : 827 - 840
  • [38] Theoretical and Therapeutic Implications of the Spasticity-Plus Syndrome Model in Multiple Sclerosis
    Bruno, Antonio
    Dolcetti, Ettore
    Centonze, Diego
    FRONTIERS IN NEUROLOGY, 2022, 12
  • [39] Gabapentin for relief of spasticity associated with multiple sclerosis
    Dunevsky, A
    Perel, AB
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 1998, 77 (05) : 451 - 454
  • [40] Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation
    Giacoppo, Sabrina
    Bramanti, Placido
    Mazzon, Emanuela
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 17 : 22 - 31